在左捆分支区域节奏和心房节节节节除后,脱极化和再极化的立即变化
Mert Doğan1, Uğur Canpolat1, Cem Çöteli1
1Hacettepe University, Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
Journal of electrocardiology
|December 4, 2024
概括
在心房节 (AVN) 切除前,左束支部区域节奏 (LBBaP) 可能提供一种更安全的方法,因为它没有显著改变与恶性心律失常相关的关键复极化参数. 这项研究研究了用LBBaP进行AVN切除后的腹腔脱极化和再极化变化.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 心室节点 (AVN) 切除可以导致恶性心律失常,原因是心室脱极化和再极化发生变化.
- 左捆分支区域步调 (LBBaP) 是一种替代步调策略.
- 研究LBBaP与AVN切除相结合的电生理学影响至关重要.
研究的目的:
- 在接受LBBaP和AVN切除的患者中评估心室脱极化和再极化变化.
- 评估LBBaP在减轻AVN切除后心律失常风险方面的安全性和有效性.
主要方法:
- 一个单一的中心,对10名患者进行了回顾性研究.
- 患者接受LBBaP,然后进行AVN切除.
- 在手术前后测量了心电图 (ECG) 参数,包括QRS持续时间,QTc,Tp-e和JT间隔.
主要成果:
- 在手术后观察到QT间隔和QRS持续时间的显著延长.
- 没有发现Tp-e和QTc间隔的显著变化.
- 指示心室再极化的JT间隔也没有显著差异.
结论:
- 与AVN切除结合的LBBaP没有显著改变Tp-e和QTc间隔,这是与恶性心律不整相关的参数.
- JT间隔保持不变,表明稳定的心室再极化.
- 对于接受AVN切除的患者来说,LBBaP似乎是一种更生理和潜在的更安全的节奏方法.
相关概念视频
Electrophysiology of Normal Cardiac Rhythm
2.1K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
2.1K
Cardiac Action Potential
973
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
973
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Disturbances in Heart Rhythm
904
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
904
Conduction System of the Heart
4.5K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
4.5K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K


